Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amir Nashat Insider Profile
4 Followers
Amir Nashat, Director at Fate Therapeutics, holds 11.03K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in aTyr Pharma (Ticker: ATYR), holds 909.09K shares in CAMP4 Therapeutics Corporation (Ticker: CAMP).
Profitable Transactions
5 out of 17 Profitable Transactions
Average Return
-25.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Amir Nashat holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 29, 2019 - Jan 29, 2020
Return:+82.70%
The most profitable trade made by Amir Nashat
Amir Nashat's Trading History
Fate Therapeutics
Aug 02, 2019
Director
Uninformative Sell
1.40M
$25.27K
aTyr Pharma
―
Director
―
―
Scholar Rock Holding
May 13, 2024
Director
Uninformative Buy
―
$1.16M
Syros Pharmaceuticals
―
Director
―
―
Cartesian Therapeutics
Jan 29, 2019
Director
Informative Buy
1.75M
$50.50M
Morphic Holding
Aug 20, 2024
―
Uninformative Sell
―
$0.00
Metacrine
Sep 22, 2020
―
Uninformative Buy
―
$103.97K
CAMP4 Therapeutics Corporation
Oct 15, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$4.92M
DNIB Unwind, Inc.
―
―
―
$0.00
Receptos
May 29, 2014
―
Uninformative Buy
―
$887.71K
List of latest transactions for each holding click on a transaction to see Amir Nashat's performance on stock
You May Also Like
Amir Nashat insider profile FAQ
What is the percentage of profitable transactions made by Amir Nashat?
The percentage of profitable transactions made by Amir Nashat is 29%.
What is the average return per transaction made by Amir Nashat?
The average return per transaction made by Amir Nashat is -25.80%.
What stocks does Amir Nashat hold?
Amir Nashat holds: FATE, ATYR, SRRK, SYRS, RNAC, MORF, MTCR, CAMP, BINDQ, RCPT stocks.
What was Amir Nashat’s latest transaction?
Amir Nashat latest transaction was an Uninformative Sell of $1.40M.
What was Amir Nashat's most profitable transaction?
Amir Nashat’s most profitable transaction was an Informative Buy of RNAC stock on January 29, 2019. The return on the trade was 82.70%.
What is Amir Nashat's role in Fate Therapeutics?
Amir Nashat's role in Fate Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.